Vaccine Portfolio (incl. Pseudomonas aeruginosa)
Prevention of bacterial infections & sepsis
ApprovedCommercial
Key Facts
Indication
Prevention of bacterial infections & sepsis
Phase
Approved
Status
Commercial
Company
About IBSS Biomed
IBSS Biomed is a well-established, revenue-generating Polish biotech firm with an 80-year legacy in vaccine production. It operates a diversified business model encompassing therapeutics (vaccines, OTC drugs), diagnostics, and specialized probiotics, with a strong focus on epidemiological security for Poland. The company possesses proprietary technology platforms, controls its own manufacturing from API to finished product, and has a significant international commercial footprint. Its strategy combines serving national public health programs with global commercial expansion and R&D in areas like novel probiotics.
View full company profile